Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Time to ambulation following angioplasty reduced on Neutralase

Sep. 21, 2000

Promising data reported from phase II trial of injectable anticoagulant

Sep. 20, 2000

Antithrombotic development candidates profiled in Bologna by Mochida

Sep. 19, 2000

Eptifibatide reduces death, myocardial infarction in unstable angina

Sep. 15, 2000

Efficacy of Org-31540/SR-90107 demonstrated in four phase III studies

Sep. 12, 2000

Structure of new oral anticoagulant revealed by DuPont at recent congress

Sep. 8, 2000

Thrombin inhibitors and their prodrugs synthesized at AstraZeneca

Sep. 7, 2000

Teijin reports on new class of factor Xa inhibitors

Sep. 7, 2000

DuPont designs potent and selective factor Xa inhibitors with excellent PK profile

Sep. 7, 2000

Factor Xa inhibitors with anticoagulant and antithrombotic effects identified at Lilly

Sep. 6, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...